5 GLP-1 Protocol Mistakes

1. Titrating Too Fast When Nausea Stops

The absence of nausea at the current dose is not a signal to increase immediately. It means tolerance has developed at that dose. The titration schedule exists to give the body time to adapt, not just to manage side effects. Jumping a dose step because you feel fine is the most common reason people end up with severe nausea two weeks later that forces them back two steps.

The standard advice: follow the schedule regardless of how well you're tolerating the current dose. If you feel great at 0.5mg, the answer is not 1mg next week. It's 0.5mg for another 3 weeks as planned.

2. Reconstituting a New Vial Without Recalculating

A 2mg vial reconstituted with 2mL gives 1mg/mL. A 5mg vial reconstituted with 4mL gives 1.25mg/mL. The draw units for the same dose are different in each case. Using the same syringe marks from a previous vial is a dosing error waiting to happen.

Recalculate at every new vial. Always. Full guide: How to Track a GLP-1 Protocol.

3. Injecting Into the Same Site Every Week

Weekly injections feel infrequent enough that site rotation seems unnecessary. After six months of weekly injections into the same right lower quadrant, absorption becomes inconsistent. Lipohypertrophy is slower to develop with weekly injections than with daily ones, but it still develops.

Rotate across at least four sites: right abdomen, left abdomen, right thigh, left thigh. One site per week means each site gets a 4-week rest between uses.

4. Interpreting Plateau as Failure

Weight loss on GLP-1 protocols is not linear. A 2-3 week plateau at a stable dose is normal. The body adapts metabolic rate in response to caloric deficit, and the plateau is often that adaptation playing out, not the compound stopping work.

The common mistake: increasing the dose at the plateau, which produces side effects without necessarily breaking the stall. What breaks most plateaus is time, protein intake, and resistance training, not a higher dose.

5. Stopping Cold Instead of Tapering

Abrupt discontinuation of a GLP-1 protocol typically produces rapid weight regain, particularly in the first 4-8 weeks. Appetite suppression ends abruptly. Gastric emptying normalizes. The metabolic adaptation the body made during the protocol partially reverses.

A slow taper across 4-8 weeks, paired with behavioral habits established during the protocol period, produces significantly better weight maintenance than stopping all at once. Plan the exit before you start.